476 related articles for article (PubMed ID: 15788576)
1. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
[TBL] [Abstract][Full Text] [Related]
2. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
von Herbay A; Vogt C; Häussinger D
AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
[TBL] [Abstract][Full Text] [Related]
3. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
4. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Ultrasound Med; 2006 Mar; 25(3):349-61. PubMed ID: 16495496
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
[TBL] [Abstract][Full Text] [Related]
6. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
[TBL] [Abstract][Full Text] [Related]
7. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
Wu W; Chen MH; Yin SS; Yan K; Fan ZH; Yang W; Dai Y; Huo L; Li JY
AJR Am J Roentgenol; 2006 Sep; 187(3):752-61. PubMed ID: 16928941
[TBL] [Abstract][Full Text] [Related]
8. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
[TBL] [Abstract][Full Text] [Related]
9. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
11. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
[TBL] [Abstract][Full Text] [Related]
12. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
13. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
14. Focal liver lesions: sinusoidal phase of CEUS.
D'Onofrio M; Martone E; Faccioli N; Zamboni G; Malagò R; Mucelli RP
Abdom Imaging; 2006; 31(5):529-36. PubMed ID: 16802201
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Malzfeldt E; Braumann D
AJR Am J Roentgenol; 2009 Sep; 193(3):709-21. PubMed ID: 19696284
[TBL] [Abstract][Full Text] [Related]
16. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH
Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883
[TBL] [Abstract][Full Text] [Related]
17. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
18. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
20. [Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders].
Tranquart F; Bleuzen A; Kissel A
J Radiol; 2004 Jun; 85(6 Pt 1):755-62. PubMed ID: 15243376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
